Labquality EQAS
Surveillance culture for multidrug resistant bacteria
CLINICAL MICROBIOLOGY
Scheme information
Service
Labquality EQAS
Scheme
Surveillance culture for multidrug resistant bacteria
Service provider
Labquality
Accreditation
ISO/EN 17043 (PT02/FINAS)
Status
Running
Target
Laboratories
Coverage
Analytical and postanalytical phase
Rounds
4
Distributions
Globally available
Coordinators
Yvonne Björkman
Experts
Kaisu Rantakokko-Jalava
Products
5071 /
Surveillance for multidrug resistant bacteria, MRSA
Samples: 1 lyophilized mixture of microbes; including pathogens and/or normal flora.
Type: Physical sample
Examinations: The scheme is intended for laboratories performing screening of MRSA (methicillin resistant Staphylococcus aureus) by culture and/or direct nucleic acid detection method.
Additional information:
5072 /
Surveillance for multidrug resistant bacteria, VRE
Samples: 1 lyophilized mixture of microbes; including pathogens and/or normal flora.
Type: Physical sample
Examinations: The scheme is intended for laboratories performing screening of VRE (vancomycin-resistant enterococci) by culture and/or direct nucleic acid detection method.
Additional information:
5073 /
Surveillance for multidrug resistant bacteria, gramnegative rods
Samples: 1 lyophilized mixture of microbes; including pathogens and/or normal flora.
Type: Physical sample
Examinations: The scheme is intended for laboratories performing screening of multidrug resistant gramnegative rods (e.g. CPE, ESBL, MDR Acinetobacter and P. aeruginosa) by culture and/or direct nucleic acid detection method.
Additional information:
Contact us
Yvonne Björkman
EQA Coordinator